| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 3951 | 2018 |
| Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ... Cell 161 (7), 1681-1696, 2015 | 2542 | 2015 |
| The molecular taxonomy of primary prostate cancer A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ... Cell 163 (4), 1011-1025, 2015 | 2457 | 2015 |
| Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018 | 2234 | 2018 |
| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 1984 | 2018 |
| Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ... Cell 173 (2), 291-304. e6, 2018 | 1851 | 2018 |
| Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC SS Ramalingam, J Vansteenkiste, D Planchard, BC Cho, JE Gray, Y Ohe, ... New England Journal of Medicine 382 (1), 41-50, 2020 | 1832 | 2020 |
| Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients JE Gershenwald, W Thompson, PF Mansfield, JE Lee, MI Colome, ... Journal of Clinical Oncology 17 (3), 976-976, 1999 | 1416 | 1999 |
| Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy GR Varadhachary, EP Tamm, JL Abbruzzese, HQ Xiong, CH Crane, ... Annals of surgical oncology 13, 1035-1046, 2006 | 972 | 2006 |
| Branching Fraction and Photon Energy Spectrum for S Chen, JW Hinson, J Lee, DH Miller, V Pavlunin, EI Shibata, IPJ Shipsey, ... Physical Review Letters 87 (25), 251807, 2001 | 919 | 2001 |
| Borderline resectable pancreatic cancer: the importance of this emerging stage of disease MHG Katz, PWT Pisters, DB Evans, CC Sun, JE Lee, JB Fleming, ... Journal of the American College of Surgeons 206 (5), 833-846, 2008 | 891 | 2008 |
| Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head DB Evans, GR Varadhachary, CH Crane, CC Sun, JE Lee, PWT Pisters, ... Journal of Clinical Oncology 26 (21), 3496-3502, 2008 | 832 | 2008 |
| Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer MA Kouvaraki, SE Shapiro, BD Fornage, BS Edeiken-Monro, SI Sherman, ... Surgery 134 (6), 946-954, 2003 | 710 | 2003 |
| Nanostructured materials for water desalination T Humplik, J Lee, SC O’hern, BA Fellman, MA Baig, SF Hassan, MA Atieh, ... Nanotechnology 22 (29), 292001, 2011 | 703 | 2011 |
| Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians YS Cho, CH Chen, C Hu, J Long, RT Hee Ong, X Sim, F Takeuchi, Y Wu, ... Nature genetics 44 (1), 67-72, 2012 | 692 | 2012 |
| Pancreaticoduodenectomy with vascular resection: margin status and survival duration JF Tseng, CP Raut, JE Lee, PWT Pisters, JN Vauthey, EK Abdalla, ... Journal of Gastrointestinal Surgery 8, 935-950, 2004 | 661 | 2004 |
| Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. FR Spitz, JL Abbruzzese, JE Lee, PW Pisters, AM Lowy, CJ Fenoglio, ... Journal of Clinical Oncology 15 (3), 928-937, 1997 | 656 | 1997 |
| Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma CP Raut, JF Tseng, CC Sun, H Wang, RA Wolff, CH Crane, R Hwang, ... Annals of surgery 246 (1), 52, 2007 | 647 | 2007 |
| Detectable clonal mosaicism from birth to old age and its relationship to cancer CC Laurie, CA Laurie, K Rice, KF Doheny, LR Zelnick, CP McHugh, ... Nature genetics 44 (6), 642-650, 2012 | 620 | 2012 |
| Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. JE Gershenwald, MI Colome, JE Lee, PF Mansfield, C Tseng, JJ Lee, ... Journal of clinical oncology 16 (6), 2253-2260, 1998 | 617 | 1998 |
